Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07600762
What this trial is testing

Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

Who this might be right for
Healthy Volunteer
AbbVie 12
Early research (Phase 1)Study completedNCT02770521
What this trial is testing

Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 23
Post-approval studies (Phase 4)Study completedNCT03667547
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Study completedNCT05590338
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 38
Early research (Phase 1)Study completedNCT05405543
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Early research (Phase 1)Study completedNCT07456059
What this trial is testing

Evaluate EDG-7500 in Caucasian and Japanese Adults

Who this might be right for
Healthy Adult Participants
Edgewise Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT05288816
What this trial is testing

Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 16
Post-approval studies (Phase 4)Study completedNCT03123848
What this trial is testing

Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT06368440
What this trial is testing

Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

Who this might be right for
Healthy Participants
AstraZeneca 39
Early research (Phase 1)Looking for participantsNCT06951880
What this trial is testing

Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Who this might be right for
Healthy Participants
AstraZeneca 160
Early research (Phase 1)Study completedNCT05337878
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 29
Early research (Phase 1)Study completedNCT04497883
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Who this might be right for
Healthy Volunteers
Shire 24
Early research (Phase 1)Study completedNCT05800444
What this trial is testing

Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants

Who this might be right for
Chronic Kidney DiseaseHealthy Volunteers
Bayer 24
Early research (Phase 1)Study completedNCT02706834
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

Who this might be right for
Dose Finding Study
Takeda 36
Early research (Phase 1)Study completedNCT06542536
What this trial is testing

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Who this might be right for
Obesity
Novo Nordisk A/S 73
Early research (Phase 1)Study completedNCT04713930
What this trial is testing

JNJ-61393215 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT04994106
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Who this might be right for
Healthy Participants
AstraZeneca 98
Early research (Phase 1)Study completedNCT05038787
What this trial is testing

LY3473329 in Healthy Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT04145128
What this trial is testing

Evaluate AG-881 in Healthy Japanese and Non-Asian Participants

Who this might be right for
Healthy Volunteers
Agios Pharmaceuticals, Inc. 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation